CD163 and non-small cell lung carcinoma: In addition to DC3-related proteins (CD1c+CD5−CD14+CD163+), the NSCLC peripheral blood CD14+ cDC2s displayed higher PD-L1, MERTK, IL-10, and IDO, compared with CD14− cDC2s.